Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Kazunori Ohnishi

Oncology Center

Hamamatsu University School of Medicine

Hamamatsu

Japan

[email]@hama-med.ac.jp

Name/email consistency: high

[Claim this account]

Affiliation

Oncology Center, Hamamatsu University School of Medicine, Hamamatsu, Japan. 2000 - 2012

References

Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study. Ohnishi, K., Nakaseko, C., Takeuchi, J., Fujisawa, S., Nagai, T., Yamazaki, H., Tauchi, T., Imai, K., Mori, N., Yagasaki, F., Maeda, Y., Usui, N., Miyazaki, Y., Miyamura, K., Kiyoi, H., Ohtake, S., Naoe, T. Cancer Sci. (2012) [Pubmed]
PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Ohnishi, K. Int. J. Clin. Oncol. (2007) [Pubmed]
Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemia. Ohnishi, K., Ino, A., Kishimoto, Y., Usui, N., Shimazaki, C., Ohtake, S., Taguchi, H., Yagasaki, F., Tomonaga, M., Hotta, T., Ohno, R. Int. J. Hematol. (2004) [Pubmed]
Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis. Ohnishi, K., Ino, T., Kishimoto, Y., Usui, N., Shimazaki, C., Ohtake, S., Taguchi, H., Kusumoto, S., Kuriyama, K., Hotta, T., Ohno, R. Cancer Chemother. Pharmacol. (2001) [Pubmed]
Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group. Ohnishi, K., Minami, S., Ueda, T., Nishimura, M., Tsubaki, K., Takemoto, Y., Takeshita, A., Sao, H., Kageyama, S., Ueda, R., Ohno, R. Int. J. Hematol. (2000) [Pubmed]
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ohnishi, K., Yoshida, H., Shigeno, K., Nakamura, S., Fujisawa, S., Naito, K., Shinjo, K., Fujita, Y., Matsui, H., Takeshita, A., Sugiyama, S., Satoh, H., Terada, H., Ohno, R. Ann. Intern. Med. (2000) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.